文献速递腹部MR

GD-EOB-DTPA增强MRI的局限性:临床参数能否预测次优肝胆期

Limitations of GD-EOB-DTPA-enhanced MRI: can clinical parameters predict suboptimal hepatobiliary phase?
PubMed 文献 · Clin Radiol · 2016-11-11

本回顾性研究纳入284例慢性肝病患者,基于LI-RADS标准将30分钟延迟肝胆期分为合格与次优,评估实验室指标预测次优肝胆期的价值。MELD评分、总胆红素和直接胆红素的ROC曲线下面积分别为0.85、0.88和0.91,对应截断值≥16.7、≥4.3 mg/dl和≥1.3 mg/dl时准确率分别为86.7%、88.2%和91.1%。作者认为这些截断值可高准确度预测次优肝胆期,前瞻性识别高危患者有助于避免对无法获益者使用更昂贵的对比剂。

要点

  • 直接胆红素≥1.3 mg/dl预测次优肝胆期准确率91.1%,阳性似然比36.4。
  • 总胆红素≥4.3 mg/dl预测次优肝胆期准确率88.2%,阳性似然比28.7。
  • MELD评分≥16.7预测次优肝胆期准确率86.7%,阳性似然比11.2。

核心结论

  • MELD评分、直接胆红素和总胆红素的截断值可高准确度预测次优肝胆期,前瞻性识别高危患者有助于避免对无法获益者使用更昂贵的对比剂。

研究设计与样本

  • 回顾性研究,纳入2011年1月1日至2014年11月30日期间因肝细胞癌筛查接受Gd-EOB-DTPA增强MRI的慢性肝病患者284例。

关键影像表现/征象

  • 基于LI-RADS标准将30分钟延迟肝胆期分为合格与次优,242例(85.2%)为合格,42例(14.8%)为次优。
  • 合格组与次优组平均年龄分别为58.5±9.7岁和55±12.7岁,差异无统计学意义(p=0.096)。
  • SGOT、SGPT和ALP在两组间差异无统计学意义。

诊断标准与关键数值

  • 预测次优肝胆期的ROC曲线下面积:MELD评分0.85(95%CI 0.79-0.91),总胆红素0.88(95%CI 0.82-0.93),直接胆红素0.91(95%CI 0.86-0.95)。
  • MELD评分≥16.7预测次优肝胆期的准确率86.7%,阳性似然比11.2。
  • 总胆红素≥4.3 mg/dl预测次优肝胆期的准确率88.2%,阳性似然比28.7。
  • 直接胆红素≥1.3 mg/dl预测次优肝胆期的准确率91.1%,阳性似然比36.4。

临床应用与阅片要点

  • 作者认为,前瞻性识别次优肝胆期高 likelihood 的患者,有助于避免对无法从该对比剂独特性能中获益的患者使用更昂贵的对比剂。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To establish cut-off levels of the clinical parameters, which would predict suboptimal 30 minutes delayed hepatobiliary phase (HBP) with high specificity.

MATERIALS AND METHODS: This retrospective study included patients with chronic liver disease who underwent hepatocellular carcinoma screening with Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) between 1 January 2011 and 30 November 2014. For each case, HBP was graded as adequate or suboptimal, based on Liver Image Reporting and Data System (LI-RADS) criteria. The following laboratory data obtained within 3 months of the MRI date was extracted: total bilirubin (TB), direct bilirubin (DB), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase (SGPT), alkaline phosphatase (ALP), albumin, activated partial thromboplastin time (aPTT), and International normalised ratio (INR). Model For End-Stage Liver Disease (MELD) scores were calculated as 3.78×ln[TB] + 11.2×ln[INR] + 9.57×ln[creatinine] + 6.43. Receiver operating characteristic (ROC) curve analysis was used to establish cut-off values for predicting suboptimal HBP.

RESULTS: Of 284 patients, 242 (85.2%) patients (91; 57.6% male) had an adequate HBP and 42 (14.8%) patients (13; 61.9% male) had suboptimal HBP, with mean ages of 58.5±9.7 years and 55±12.7 years, respectively (p=0.096). Areas under the ROC curve for predicting suboptimal HBP were 0.85 (95%CI 0.79-0.91) for the MELD score, 0.88 (95%CI 0.82-0.93) for TB, and 0.91 (95%CI 0.86-0.95) for DB. Accuracy, positive likelihood ratios and cut-off values for predicting suboptimal HBP were, respectively: 86.7% and 11.2 for the MELD score ≥16.7, 88.2% and 28.7 for TB ≥4.3 mg/dl, and 91.1% and 36.4 for DB ≥1.3 mg/dl. SGOT, SGPT, and ALP were not statistically significantly different between the groups.

CONCLUSION: Cut-off levels of MELD score, DB, and TB can predict an suboptimal HBP with high accuracy. Prospective identification of patients with a high likelihood of an suboptimal HBP can help to avoid administering a more costly agent to patients who would not benefit from its unique properties.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Kobi M, Paroder V, Flusberg M, et al. Limitations of GD-EOB-DTPA-enhanced MRI: can clinical parameters predict suboptimal hepatobiliary phase? Clin Radiol. 2016. PMID: 27842889. doi:10.1016/j.crad.2016.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。